by Lenkinski, R.E. et al.
Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
In this work, we examined this assumption by determining the effects of six gadolinium-based contrast agents: Magnevist, Multihance, Omniscan, Optimark, ProHance, and Dotarem, on the Cho peak in phantoms and in a rat model for breast cancer.
Magn. Reson. Med. 2009; 6:1286-92